{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:04:55Z","timestamp":1791612295456,"version":"4.3.4"},"reference-count":75,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Center","doi-asserted-by":"publisher","award":["2019\/33\/B\/NZ7\/02699"],"award-info":[{"award-number":["2019\/33\/B\/NZ7\/02699"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"National Science Center","doi-asserted-by":"publisher","award":["2\/566516\/SPUB\/SP\/2023"],"award-info":[{"award-number":["2\/566516\/SPUB\/SP\/2023"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Education and Science","award":["2019\/33\/B\/NZ7\/02699"],"award-info":[{"award-number":["2019\/33\/B\/NZ7\/02699"]}]},{"name":"Ministry of Education and Science","award":["2\/566516\/SPUB\/SP\/2023"],"award-info":[{"award-number":["2\/566516\/SPUB\/SP\/2023"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>The role of endothelial nitric oxide synthase (eNOS) in the regulation of a variety of biological processes is well established, and its dysfunction contributes to brain pathologies, including schizophrenia or Alzheimer\u2019s disease (AD). Positive allosteric modulators (PAMs) of metabotropic glutamate (mGlu) receptors were shown to be effective procognitive compounds, but little is known about their impact on eNOS expression and stability. Here, we investigated the influence of the acute and chronic administration of LY487379 or CDPPB (mGlu2 and mGlu5 PAMs), on eNOS expression in the mouse brain and the effect of the joint administration of the ligands with nitric oxide (NO) releasers, spermineNONOate or DETANONOate, in different combinations of doses, on MK-801- or scopolamine-induced amnesia in the novel object recognition (NOR) test. Our results indicate that both compounds provoked eNOS monomer formation, and CDPPB at a dose of 5 mg\/kg exaggerated the effect of MK-801 or scopolamine. The coadministration of spermineNONOate or DETANONOate enhanced the antiamnesic effect of CDPPB or LY487379. The best activity was observed for ineffective or moderate dose combinations. The results indicate that treatment with mGluR2 and mGluR5 PAMs may be burdened with the risk of promoting eNOS uncoupling through the induction of dimer dissociation. Administration of the lowest possible doses of the compounds with NO\u2022 donors, which themselves have procognitive efficacy, may be proposed for the treatment of schizophrenia or AD.<\/jats:p>","DOI":"10.3390\/molecules29030627","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T07:49:47Z","timestamp":1706600987000},"page":"627","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Impact of LY487379 or CDPPB on eNOS Expression in the Mouse Brain and the Effect of Joint Administration of Compounds with NO\u2022 Releasers on MK-801- or Scopolamine-Driven Cognitive Dysfunction in Mice"],"prefix":"10.3390","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0408-5262","authenticated-orcid":false,"given":"Agata","family":"P\u0142oska","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory Diagnostics\u2014Fahrenheit Biobank BBMRI.pl, Medical University of Gdansk, 7 Debinki Street, 80-211 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Siekierzycka","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Diagnostics\u2014Fahrenheit Biobank BBMRI.pl, Medical University of Gdansk, 7 Debinki Street, 80-211 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Cie\u015blik","sequence":"additional","affiliation":[{"name":"Maj Institute of Pharmacology Polish Academy of Sciences, 12 Smetna Street, 31-343 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6807-217X","authenticated-orcid":false,"given":"Lawrence W.","family":"Dobrucki","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Diagnostics\u2014Fahrenheit Biobank BBMRI.pl, Medical University of Gdansk, 7 Debinki Street, 80-211 Gdansk, Poland"},{"name":"Department of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA"},{"name":"Beckman Institute for Advanced Science and Technology, Urbana, IL 61801, USA"},{"name":"Department of Biomedical and Translational Sciences, Carle-Illinois College of Medicine, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7270-1592","authenticated-orcid":false,"given":"Leszek","family":"Kalinowski","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Diagnostics\u2014Fahrenheit Biobank BBMRI.pl, Medical University of Gdansk, 7 Debinki Street, 80-211 Gdansk, Poland"},{"name":"BioTechMed Center, Department of Mechanics of Materials and Structures, Gdansk University of Technology, 11\/12 Narutowicza Steet, 80-223 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2052-0973","authenticated-orcid":false,"given":"Joanna M.","family":"Wiero\u0144ska","sequence":"additional","affiliation":[{"name":"Maj Institute of Pharmacology Polish Academy of Sciences, 12 Smetna Street, 31-343 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Janaszak-Jasiecka, A., P\u0142oska, A., Wiero\u0144ska, J.M., Dobrucki, L.W., and Kalinowski, L. (2023). Endothelial Dysfunction Due to ENOS Uncoupling: Molecular Mechanisms as Potential Therapeutic Targets. Cell. Mol. Biol. Lett., 28.","DOI":"10.1186\/s11658-023-00423-2"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/CIRCRESAHA.116.309686","article-title":"Loss of Endothelial Nitric Oxide Synthase Promotes P25 Generation and Tau Phosphorylation in a Murine Model of Alzheimer\u2019s Disease","volume":"119","author":"Austin","year":"2016","journal-title":"Circ. Res."},{"key":"ref_3","first-page":"695","article-title":"The Protective Role of Nitric Oxide in the Brain Ischemia","volume":"51","author":"Dobrucki","year":"2000","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00008877-199508000-00007","article-title":"Modulation of Learning Processes by Ionotropic Glutamate Receptor Ligands","volume":"6","author":"Danysz","year":"1995","journal-title":"Behav. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/bj3570593","article-title":"Nitric Oxide Synthases: Structure, Function and Inhibition","volume":"357","author":"Alderton","year":"2001","journal-title":"Biochem. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1161\/01.CIR.0000129087.81352.7A","article-title":"Race-Specific Differences in Endothelial Function: Predisposition of African Americans to Vascular Diseases","volume":"109","author":"Kalinowski","year":"2004","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1523\/JNEUROSCI.19-14-05910.1999","article-title":"Neuronal Nitric Oxide Synthase Activation and Peroxynitriteformation in Ischemic Stroke Linked to Neural Damage","volume":"19","author":"Eliasson","year":"1999","journal-title":"J. Neurosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.18388\/abp.2004_3584","article-title":"Endothelial NADH\/NADPH-Dependent Enzymatic Sources of Superoxide Production: Relationship to Endothelial Dysfunction","volume":"51","author":"Kalinowski","year":"2004","journal-title":"Acta Biochim. Pol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"00083","DOI":"10.3389\/fpsyt.2017.00083","article-title":"Neurovascular Unit Dysfunction and Blood\u2013Brain Barrier Hyperpermeability Contribute to Schizophrenia Neurobiology: A Theoretical Integration of Clinical and Experimental Evidence","volume":"8","author":"Najjar","year":"2017","journal-title":"Front. Psychiatry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/jnc.13205","article-title":"Uncoupling of Endothelial Nitric Oxide Synthase in Cerebral Vasculature of Tg2576 Mice","volume":"134","author":"Santhanam","year":"2015","journal-title":"J. Neurochem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12974-015-0304-x","article-title":"Amyloid \u03b2 Peptide-Induced Inhibition of Endothelial Nitric Oxide Production Involves Oxidative Stress-Mediated Constitutive ENOS\/HSP90 Interaction and Disruption of Agonist-Mediated Akt Activation","volume":"12","author":"Lamoke","year":"2015","journal-title":"J. Neuroinflamm."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.nbd.2015.08.014","article-title":"Vascular Dysfunction in the Pathogenesis of Alzheimer\u2019s Disease\u2014A Review of Endothelium-Mediated Mechanisms and Ensuing Vicious Circles","volume":"82","author":"Venneri","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jnr.22527","article-title":"The Case for Blood\u2013Brain Barrier Dysfunction in the Pathogenesis of Alzheimer\u2019s Disease","volume":"89","author":"Jeynes","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"ref_14","first-page":"191863","article-title":"The Role of the Blood-Brain Barrier in the Pathogenesis of Senile Plaques in Alzheimer\u2019s Disease","volume":"2014","author":"Provias","year":"2014","journal-title":"Int. J. Alzheimers Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3233\/JAD-2006-9209","article-title":"Molecular Indices of Oxidative Stress and Mitochondrial Dysfunction Occur Early and often Progress with Severity of Alzheimer\u2019s Disease","volume":"9","author":"Wands","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1124\/pharmrev.121.000540","article-title":"Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease","volume":"74","author":"Luessen","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1124\/molpharm.121.000460","article-title":"Metabotropic Glutamate Receptors As Emerging Targets for the Treatment of Schizophrenia","volume":"101","author":"Dogra","year":"2022","journal-title":"Mol. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coph.2018.02.003","article-title":"The Therapeutic Potential of Metabotropic Glutamate Receptor Modulation for Schizophrenia","volume":"38","author":"Stansley","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2174\/1570159X13666150421003225","article-title":"The Role of MGlu Receptors in Hippocampal Plasticity Deficits in Neurological and Psychiatric Disorders: Implications for Allosteric Modulators as Novel Therapeutic Strategies","volume":"14","author":"Senter","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.pbb.2011.04.013","article-title":"Glutamate Receptors in Preclinical Research on Alzheimer\u2019s Disease: Update on Recent Advances","volume":"100","author":"Hu","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"109569","DOI":"10.1016\/j.neuropharm.2023.109569","article-title":"GPCR Interactions Involving Metabotropic Glutamate Receptors and Their Relevance to the Pathophysiology and Treatment of CNS Disorders","volume":"235","author":"Nicoletti","year":"2023","journal-title":"Neuropharmacology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00004647-200109000-00001","article-title":"Metabotropic Glutamate Receptor Subtypes as Targets for Neuroprotective Drugs","volume":"21","author":"Bruno","year":"2001","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.neuron.2017.03.016","article-title":"Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders","volume":"94","author":"Foster","year":"2017","journal-title":"Neuron"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm1632","article-title":"Activation of MGlu2\/3 Receptors as a New Approach to Treat Schizophrenia: A Randomized Phase 2 Clinical Trial","volume":"13","author":"Patil","year":"2007","journal-title":"Nat. Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Downing, A.C.M., Kinon, B.J., Millen, B.A., Zhang, L., Liu, L., Morozova, M.A., Brenner, R., Rayle, T.J., Nisenbaum, L., and Zhao, F. (2014). A Double-Blind, Placebo-Controlled Comparator Study of LY2140023 Monohydrate in Patients with Schizophrenia. BMC Psychiatry, 14.","DOI":"10.1186\/s12888-014-0351-3"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopsych.2015.03.016","article-title":"Exploratory Analysis for a Targeted Patient Population Responsive to the Metabotropic Glutamate 2\/3 Receptor Agonist Pomaglumetad Methionil in Schizophrenia","volume":"78","author":"Kinon","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/JCP.0b013e318218dcd5","article-title":"A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients with DSM-IV Schizophrenia","volume":"31","author":"Kinon","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejphar.2010.02.058","article-title":"Metabotropic Glutamate 2\/3 (MGlu2\/3) Receptors, Schizophrenia and Cognition","volume":"639","author":"Marek","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Budgett, R.F., Bakker, G., Sergeev, E., Bennett, K.A., and Bradley, S.J. (2022). Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases?. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.893422"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/13543776.2019.1637421","article-title":"MGluR2 Positive Allosteric Modulators: An Updated Patent Review (2013\u20132018)","volume":"29","author":"Trabanco","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Witkin, J.M., Pandey, K.P., and Smith, J.L. (2022). Clinical Investigations of Compounds Targeting Metabotropic Glutamate Receptors. Pharmacol. Biochem. Behav., 219.","DOI":"10.1016\/j.pbb.2022.173446"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2760","article-title":"Allosteric Modulators of GPCRs: A Novel Approach for the Treatment of CNS Disorders","volume":"8","author":"Conn","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tips.2008.10.006","article-title":"Activation of Metabotropic Glutamate Receptors as a Novel Approach for the Treatment of Schizophrenia","volume":"30","author":"Conn","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and Its Implication for Treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.niox.2021.12.003","article-title":"Procognitive Activity of Nitric Oxide Inhibitors and Donors in Animal Models","volume":"119","author":"Kalinowski","year":"2022","journal-title":"Nitric Oxide"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Cie\u015blik, P., Borska, M., and Wiero\u0144ska, J.M. (2023). A Comparative Study of the Impact of NO-Related Agents on MK-801- or Scopolamine-Induced Cognitive Impairments in the Morris Water Maze. Brain Sci., 13.","DOI":"10.3390\/brainsci13030410"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"00923","DOI":"10.3389\/fphar.2020.00923","article-title":"Recent Developments in Pharmacological Effect, Mechanism and Application Prospect of Diazeniumdiolates","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Cie\u015blik, P., Siekierzycka, A., Radulska, A., P\u0142oska, A., Burnat, G., Bra\u0144ski, P., Kalinowski, L., and Wiero\u0144ska, J.M. (2021). Nitric Oxide-Dependent Mechanisms Underlying MK-801- or Scopolamine-Induced Memory Dysfunction in Animals: Mechanistic Studies. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212282"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1124\/mol.64.4.798","article-title":"Pharmacological Characterization and Identification of Amino Acids Involved in the Positive Modulation of Metabotropic Glutamate Receptor Subtype 2","volume":"64","author":"Schaffhauser","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1021\/jm049400d","article-title":"Discovery of Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 5 from a Series of N-(1,3-Diphenyl-1H-Pyrazol-5-Yl)Benzamides That Potentiate Receptor Function In Vivo","volume":"47","author":"Lindsley","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Cie\u015blik, P., Radulska, A., Pelikant-Ma\u0142ecka, I., P\u0142oska, A., Kalinowski, L., and Wiero\u0144ska, J.M. (2019). Reversal of MK-801-Induced Disruptions in Social Interactions and Working Memory with Simultaneous Administration of LY487379 and VU152100 in Mice. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112781"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"107866","DOI":"10.1016\/j.neuropharm.2019.107866","article-title":"Simultaneous Activation of MGlu2 and Muscarinic Receptors Reverses MK-801-Induced Cognitive Decline in Rodents","volume":"174","author":"Domin","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuint.2015.03.010","article-title":"MGlu5-GABAB Interplay in Animal Models of Positive, Negative and Cognitive Symptoms of Schizophrenia","volume":"88","author":"Gruca","year":"2015","journal-title":"Neurochem. Int."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Hagena, H., and Manahan-Vaughan, D. (2022). Role of MGlu5 in Persistent Forms of Hippocampal Synaptic Plasticity and the Encoding of Spatial Experience. Cells, 11.","DOI":"10.3390\/cells11213352"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1021\/acsptsci.9b00017","article-title":"MGlu5 Positive Allosteric Modulators Facilitate Long-Term Potentiation via Disinhibition Mediated by MGlu5-Endocannabinoid Signaling","volume":"2","author":"Xiang","year":"2019","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuropharm.2016.06.003","article-title":"Metabotropic Glutamate Receptor, MGlu5, Mediates Enhancements of Hippocampal Long-Term Potentiation after Environmental Enrichment in Young and Old Mice","volume":"115","author":"Buschler","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1523\/JNEUROSCI.1519-16.2016","article-title":"Activation of Group II Metabotropic Glutamate Receptors Promotes LTP Induction at Schaffer Collateral-CA1 Pyramidal Cell Synapses by Priming NMDA Receptors","volume":"36","author":"Rosenberg","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuroscience.2008.07.045","article-title":"A Specific Role for Group II Metabotropic Glutamate Receptors in Hippocampal Long-Term Depression and Spatial Memory","volume":"158","author":"Altinbilek","year":"2009","journal-title":"Neuroscience"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S2215-0366(17)30293-6","article-title":"The Blood\u2013Brain Barrier in Psychosis","volume":"5","author":"Pollak","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.jalz.2018.06.2857","article-title":"Blood-Brain Barrier Breakdown, Neuroinflammation, and Cognitive Decline in Older Adults","volume":"14","author":"Bowman","year":"2018","journal-title":"Alzheimers Dement."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"P\u0142oska, A., Cie\u015blik, P., Siekierzycka, A., Kalinowski, L., and Wiero\u0144ska, J.M. (2021). Neurochemical Changes Underlying Cognitive Impairment in Olfactory Bulbectomized Rats and the Impact of the MGlu5-Positive Allosteric Modulator CDPPB. Brain Res., 1768.","DOI":"10.1016\/j.brainres.2021.147577"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/jnc.12334","article-title":"Endothelial Nitric Oxide Deficiency Promotes Alzheimer\u2019s Disease Pathology","volume":"127","author":"Austin","year":"2013","journal-title":"J. Neurochem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.fct.2013.07.013","article-title":"Alzheimer\u2019s Disease Treated Patients Showed Different Patterns for Oxidative Stress and Inflammation Markers","volume":"61","author":"Gubandru","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3233\/JAD-2007-11208","article-title":"Nitric Oxide and Nitroxidative Stress in Alzheimer\u2019s Disease","volume":"11","author":"Malinski","year":"2007","journal-title":"J. Alzheimers Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.psychres.2017.03.038","article-title":"Oxidative and Nitrosative Stress Biomarkers in Chronic Schizophrenia","volume":"253","author":"Boll","year":"2017","journal-title":"Psychiatry Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejmech.2018.11.049","article-title":"Design and Development of Some Phenyl Benzoxazole Derivatives as a Potent Acetylcholinesterase Inhibitor with Antioxidant Property to Enhance Learning and Memory","volume":"163","author":"Srivastava","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bioorg.2018.12.017","article-title":"Biphenyl-3-Oxo-1,2,4-Triazine Linked Piperazine Derivatives as Potential Cholinesterase Inhibitors with Anti-Oxidant Property to Improve the Learning and Memory","volume":"85","author":"Tripathi","year":"2019","journal-title":"Bioorg. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Zoupa, E., and Pitsikas, N. (2021). The Nitric Oxide (NO) Donor Sodium Nitroprusside (SNP) and Its Potential for the Schizophrenia Therapy: Lights and Shadows. Molecules, 26.","DOI":"10.3390\/molecules26113196"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbr.2014.06.008","article-title":"The Role of Nitric Oxide in the Object Recognition Memory","volume":"285","author":"Pitsikas","year":"2015","journal-title":"Behav. Brain Res."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Vartzoka, F., Ozenoglu, E., and Pitsikas, N. (2023). The Nitric Oxide (NO) Donor Molsidomine Attenuates Memory Impairments Induced by the D1\/D2 Dopaminergic Receptor Agonist Apomorphine in the Rat. Molecules, 28.","DOI":"10.3390\/molecules28196861"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00213-015-4181-x","article-title":"The Nitric Oxide Donor Sodium Nitroprusside Attenuates Recognition Memory Deficits and Social Withdrawal Produced by the NMDA Receptor Antagonist Ketamine and Induces Anxiolytic-like Behaviour in Rats","volume":"233","author":"Trevlopoulou","year":"2016","journal-title":"Psychopharmacology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.brainresbull.2019.02.008","article-title":"Effects of Sodium Nitroprusside in the Acute Dizocilpine (MK-801) Animal Model of Schizophrenia","volume":"147","author":"Wang","year":"2019","journal-title":"Brain Res. Bull."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.psychres.2018.08.079","article-title":"Sodium Nitroprusside Treatment for Psychotic Symptoms and Cognitive Deficits of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"269","author":"Wang","year":"2018","journal-title":"Psychiatry Res."},{"key":"ref_64","first-page":"152","article-title":"Sodium Nitroprusside: Twenty Years and Counting","volume":"81","author":"Friederich","year":"1995","journal-title":"Anesth. Analg."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1517\/13543784.12.3.455","article-title":"The Potential of Nitric Oxide Therapeutics in Stroke","volume":"12","author":"Willmot","year":"2003","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3171\/jns.1997.87.5.0746","article-title":"Reversal and Prevention of Cerebral Vasospasm by Intracarotid Infusions of Nitric Oxide Donors in a Primate Model of Subarachnoid Hemorrhage","volume":"87","author":"Pluta","year":"1997","journal-title":"J. Neurosurg."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0006-8993(00)02095-3","article-title":"Reduction of Infarct Size by the NO Donors Sodium Nitroprusside and Spermine\/NO after Transient Focal Cerebral Ischemia in Rats","volume":"865","author":"Salom","year":"2000","journal-title":"Brain Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.niox.2013.12.002","article-title":"A Comparative Study of NONOate Based NO Donors: Spermine NONOate Is the Best Suited NO Donor for Angiogenesis","volume":"36","author":"Majumder","year":"2014","journal-title":"Nitric Oxide"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/j.1476-5381.2009.00400.x","article-title":"The NO Donor DETA-NONOate Reversibly Activates an Inward Current in Neurones and Is Not Mediated by the Released Nitric Oxide","volume":"158","author":"Thompson","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_70","first-page":"79","article-title":"Dementia","volume":"84","author":"Cunningham","year":"2015","journal-title":"Ulster Med. J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"H80","DOI":"10.1152\/ajpheart.00506.2018","article-title":"Potential Pitfalls in Analyzing Structural Uncoupling of Enos: Aging Is Not Associated with Increased Enzyme Monomerization","volume":"316","author":"Chang","year":"2019","journal-title":"Am. J. Physiol. Hear. Circ. Physiol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Cie\u015blik, P., Radulska, A., Burnat, G., Kalinowski, L., and Wiero\u0144ska, J.M. (2021). Serotonergic\u2013Muscarinic Interaction within the Prefrontal Cortex as a Novel Target to Reverse Schizophrenia-Related Cognitive Symptoms. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168612"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbr.2015.08.040","article-title":"Prolonged Reversal of the Phencyclidine-Induced Impairment in Novel Object Recognition by a Serotonin (5-HT)1A-Dependent Mechanism","volume":"301","author":"Horiguchi","year":"2016","journal-title":"Behav. Brain Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuropharm.2016.07.001","article-title":"Biased Allosteric Agonism and Modulation of Metabotropic Glutamate Receptor 5: Implications for Optimizing Preclinical Neuroscience Drug Discovery","volume":"115","author":"Sengmany","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1042\/CS20180374","article-title":"Biased Agonism and Allosteric Modulation of Metabotropic Glutamate Receptor 5","volume":"132","author":"Trinh","year":"2018","journal-title":"Clin. Sci."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/3\/627\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:50:59Z","timestamp":1760104259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/3\/627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":75,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["molecules29030627"],"URL":"https:\/\/doi.org\/10.3390\/molecules29030627","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,29]]}}}